300502:SZSEEoptolink Technology Inc., Ltd. Class A Analysis
Data as of 2026-08-22 - not real-time
CN¥442.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At ¥442.00, Eoptolink Technology Inc., Ltd. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 15.5% over the past 30 days. With RSI at 48.7 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near ¥347.00 and resistance around ¥492.41.
Multiples put this in overvalued territory: 61.0 times earnings against the sector's 35.2. Consensus targets land 46.0% above where the shares trade now. Revenue is growing at 105.8% on a 36.9% profit margin. The 0.23% dividend yield looks covered by current payout levels.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 111.5%, a beta of 1.01 and a maximum drawdown of 39.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Multiples put this in overvalued territory: 61.0 times earnings against the sector's 35.2. Consensus targets land 46.0% above where the shares trade now. Revenue is growing at 105.8% on a 36.9% profit margin. The 0.23% dividend yield looks covered by current payout levels.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 111.5%, a beta of 1.01 and a maximum drawdown of 39.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 369.42
- MACD momentum is positive
- 30-day price change of -15.5%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 61.0 versus sector average of 35.2
- Trading above the 200-day average of 369.42
- Analyst targets imply +46.0% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 61.0 versus sector average of 35.2
- Analyst targets imply +46.0% versus the current price
- Profit margin of 36.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth105.80%
Profit Margin36.87%
P/E Ratio61.0
ROE70.67%
ROA35.32%
Debt/Equity0.07
P/B Ratio30.2
Op. Cash FlowCN¥8.2B
Free Cash FlowCN¥3.3B
Industry P/E35.2
Technical Analysis
TrendNeutral
RSI48.7
SupportCN¥347.00
ResistanceCN¥492.41
MA 20CN¥425.14
MA 50CN¥493.59
MA 200CN¥369.42
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair ValueCN¥87.17
Target PriceCN¥645.32
Upside/Downside46.00%
GradeOvervalued
TypeGrowth
Dividend Yield0.23%
Risk Assessment
Beta1.01
Volatility111.53%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.